Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) Sees Significant Drop in Short Interest

Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) was the recipient of a significant drop in short interest during the month of March. As of March 13th, there was short interest totaling 473 shares, a drop of 81.2% from the February 26th total of 2,513 shares. Based on an average daily trading volume, of 1,606 shares, the days-to-cover ratio is currently 0.3 days.

Hikma Pharmaceuticals Trading Up 2.9%

Shares of HKMPY traded up $0.95 on Thursday, reaching $34.00. The company’s stock had a trading volume of 134 shares, compared to its average volume of 1,931. Hikma Pharmaceuticals has a twelve month low of $31.80 and a twelve month high of $56.94. The firm has a fifty day moving average of $39.31 and a 200-day moving average of $42.45.

About Hikma Pharmaceuticals

Hikma Pharmaceuticals is a multinational pharmaceutical company founded in Amman, Jordan, in 1978. Headquartered in London, the company develops, manufactures and markets a broad range of branded and non-branded generic medicines, as well as speciality injectable products. Over four decades, Hikma has grown from a regional pharmaceutical supplier to a global healthcare provider, maintaining a focus on quality manufacturing and regulatory compliance.

The company operates across three core business segments: branded generics, speciality injectables and non-branded generics.